Saturday, 17 October 2026European Markets
ExploreSearch
ViaNews EU
stockMarket

NR21 Stock Was Up By 9.89% On Wednesday

Loading stream...

(vianews) - the market ended the session with nr21 (nr21.pa) rising 9.89% to €100.00 on wednesday while cac 40 jumped 0.21% to €7,549.44.

nr21's last close was €91.00, 60.09% under its 52-week high of €228.00.

about nr21

nr21 société anonyme does not have significant operations. previously, it was involved in design and distribution of underwear and indoor clothing for men, women, and children. the company is based in paris, france.

earnings per share

as for profitability, nr21 has a trailing twelve months eps of €-1.36.

moving average

nr21's value is below its 50-day moving average of €101.02 and way below its 200-day moving average of €135.93.

more news about nr21 (nr21.pa).

Categories

stockMarket

Tags

Market-Close NowStock PriceNR21.PAClosesStock Market NowEnd of DayPrice UpMarket CloseStock Price UpNR21Stock MarketStock
What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Autumn 2026 Governance Reshuffle: CEO Successions, Activist Settlements and Corporate Separations
Across sectors, boards are replacing or rotating leadership (Bausch + Lomb's abrupt CEO exit, Keyser's move to advisor, Deputy CEO promotions, Brown-Forman and BellRing successions). At the same time, activist pressure is being settled through cooperation agreements and board seats (Stride/Fivespan, Al Shams) and through structural separations (National Fuel's IUG spin-out, NGEx). The common thread is boards using governance levers such as new committees, advisory seats and planned succession to reset capital allocation and strategy. Public messaging stresses continuity and partnership, but the number of interim appointments and activist-driven changes points to underlying pressure.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,986
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,986 facts checked against source5,384 source documents archived
Query this data → isubstrate.com